Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Conditions: Pulmonary Aspergillosis - Invasive; Acute Myeloid Leukemia Interventions: Drug: F901318; Drug: Caspofungin Sponsors: F2G Ltd.; University Hospital of Cologne Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials